Proinflammatory macrophage migratory inhibition factor and interleukin-6 are concentrated in pleural effusion of human fetuses with prenatal chylothorax

Prenatal Diagnosis

Volumn 27, Issue 5, 2007, Pages 435-441

  Chen, Ming ^a,b,c   Hsieh, Chang Yao ^c,d   Shih, Jin Chung ^c   Chou, Chia Hung ^d   Ma, Gwo Chin ^a,b   Chen, Tze Ho ^a   Lee, Tsung Hsien ^c   Tsai, Horng Der ^a   Cameron, Alan D ^e   Chen, Chih Ping ^f,g,h  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e QUEEN MOTHER S HOSPITAL   (United Kingdom)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Chylothorax; Cytokines; Growth factors; Inflammation

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; ALPHA CHEMOKINE; VASCULOTROPIN A;

AMNIOCENTESIS; AMNION FLUID; ANEMIA; ARTICLE; CAPILLARY PERMEABILITY; CHYLOTHORAX; CLINICAL ARTICLE; CONTROLLED STUDY; CORDOCENTESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS CIRCULATION; GESTATIONAL AGE; HUMAN; MALE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; THORACOCENTESIS; UMBILICAL CORD BLOOD; CASE CONTROL STUDY; EVALUATION; FETUS BLOOD; IMMUNOLOGY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DEVELOPMENT; SECOND TRIMESTER PREGNANCY;

AMNIOTIC FLUID; CASE-CONTROL STUDIES; CHEMOKINES, CXC; CHYLOTHORAX; FEMALE; FETAL BLOOD; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; PLEURAL EFFUSION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34347223262     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1704     Document Type: Article

References (49)

1. Achildi O, Smith BP, Grewal H. 2006. Thoracoscopic ligation of the thoracic duct in a child with spontaneous chylothorax. J Laparoendosc Adv Surg Tech A 16: 546-549.
2. Alexandrakis MG, Coulocheri SA, Bouros D, Mandalaki K, Karkavitsas N, Eliopoulos GD. 2000. Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Oncol Rep 7: 1327-1332.
3. Antony VB. 2003. Immunological mechanisms in pleural disease. Eur Respir J 21: 539-544.
4. Bartha JL, Comino-Delgado R. 2001. Fetal chylothorax response to maternal dietary treatment. Obstet Gynecol 97: 820-823.
5. Benelli R, Lorusso G, Albini A, Noonan DM. 2006. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des 12: 3101-3115.
6. Castillo RA, Dcvoe LD, Hadi HA, Martin S, Geist D. 1986. Nonimmune hydrops fetalis: clinical experience and factors related to a poor outcome. Am J Obstet Gynecol 155: 812-816.
7. Chaiworapongsa T, Romero R, Espinoza J, et al. 2005. Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 18: 405-416.
8. Chang YL, Lien R, Wang CJ, Chang SD, Soong YK. 2005. Congenital chylothorax in three siblings. Am J Obstet Gynecol 192: 2065-2066.
9. Chen CP, Chang TY, Wang W. 2001. Resolution of fetal bilateral chylothorax and ascites after two unilateral thoracocentesis. Ultrasound Obstet Gynecol 18: 401-406.
10. Chen M, Chen CP, Shih JC, Chou HC, Yu CL, Hsieh CY. 2005a. Antenatal treatment of chylothorax and cystic hygroma with OK432 in non-immune hydrops fetalis. Fetal Diagn Ther 20: 309-315.
11. Chen M, Shih JC, Wang BT, Chen CP, Yu CL. 2005b. Fetal OK-432 pleurodesis: complete or incomplete? Ultrasound Obstet Gynecol 26: 791-793.
12. Chiesa C, Pellegrini G, Panero A, et al. 2003. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49: 60-68.
13. Chung CL, Chen YC, Chang SC. 2003. Effect of repeated thoracocentesis on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 123: 1188-1195.
14. D'Alfonso A, Piancatelli D, Macarrone D, Adorno D, Iovenitti P, Carta G. 2006. Cytokine levels in amniotic fluid: a marker of preterm labor? Clin Exp Obstet Gynecol 33: 34-35.
15. Daniel-Spiegel E, Ghalamkarpour A, Spigel R, et al. 2005. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenat Diagn 25: 1015-1018.
16. Doerr CH, Allen MS, Nichols FC III, Ryu JH. 2005. Etiology of chylothorax in 203 patients. Mayo Clin Proc 80: 867-870.
17. Donn RP, Ray DW. 2004. Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182: 1-9.
18. Evans AL, Brice G, Sotirova V, et al. 1999. Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 64: 547-555.
19. Gerritsen ME. 2005. HGF and VEGF: a dynamic duo. Circ Res 96: 272-273.
20. Holst RM, Mattsby-Baltzer I, Wennerholm UB, Hagberg H, Jacobsson B. 2005. Interleukin-6 and interleukin-8 in cervical fluid in a population of Swedish women in preterm labor: relationship to microbial invasion of the amniotic fluid, intra-amniotic inflammation, and preterm delivery. Acta Obstet Gynecol Scand 84: 551-557.
21. Hosoya Y, Kobayashi E, Takizawa T, et al. 2005. Effect of intraperitoneal neutrophils induced by OK432 on malignant ascites. Surg Today 35: 60-66.
22. Jorgensen C, Brocks V, Bang J, Jorgensen FS, Ronsbro L. 2003. Treatment of severe fetal chylothorax associated with pronounced hydrops with intrapleural injection of OK-432. Ultrasound Obstet Gynecol 21: 66-69.
23. Karkkainen MJ, Alitalo K. 2002. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Semin Cell Dev Biol 13: 9-18.
24. Karkkainen MJ, Ferrell RE, Lawrence EC, et al. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25: 153-159.
25. Karkkainen MJ, Sarristo A, Jussila K, et al. 2001. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98: 12677-12682.
26. Kurauchi O, Itakura A, Ando H, Kuno N, Mizutani S, Tomoda Y. 1995. The concentration of hepatocyte growth factor (HGF) in human amniotic fluid at second trimester: relation to fetal birth weight. Horm Metab Res 27: 335-338.
27. Ohnishi Y, Yamashiro C, Yanagihara T, Hata T. 1999. Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth. Hum Reprod 14: 2625-2628.
28. Okawa T, Takano Y, Fujimori K, Yanagida K, Sato A. 2001. A new fetal therapy for chylothorax: pleurodesis with OK-432. Ultrasound Obstet Gynecol 18: 376-377.
29. Oonakahara K, Malsuyama W, Higashimoto I, Kawabata M, Arimura K, Osame M. 2004. Stromal-dcrived factor-1 alpha/ CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space. Am J Respir Cell Mol Biol 30: 671-677.
30. Parra J, Amenedo M, Mûniz-Dîaz E, et al. 2003. A new successful therapy for fetal chylothorax by intrapleural injection of maternal blood. Ultrasound Obstet Gynecol 22: 290-294.
31. Pettersson T, Welin MG, Weber TH. 1982. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions. J Clin Lab Immunol 8: 107-111.
32. Picone O, Benachi A, Mandelbrodt L, Ruano R, Dumez Y, Dommergues M. 2004. Thoracoamniotic shunting for fetal pleural effusions with hydrops. Am J Obstet Gynecol 191: 2047-2050.
33. Remick DG. 2005. Interleukin-8. Crit Care Med 33: s466-s467.
34. Sack U, Hoffmann M, Zhao XJ, et al. 2005. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 25: 600-604.
35. Schluter G, Steckel M, Schiffmann H, et al. 2005. Prenatal DNA diagnosis of Noonan syndrome in a fetus with massive hygroma colli, pleural effusion and ascites. Prenat Diagn 25: 574-576.
36. Song M, Kellum JA. 2005. Interleukin-6. Crit Care Med. 33: 463-465.
37. Sugiura K, Tanabe Y, Oqawa T, Tokushima T. 2005. Localization of chyle leakage site in postoperative chylothorax by oral administration of I-123 BMIPP. Ann Nucl Med 19: 597-601.
38. Tanemura M, Nishikawa N, Kojima K, Suzuki Y, Suzumori K. 2001. A case of successful fetal therapy for congenital chylothorax by intrapleural injection of OK-432. Ultrasound Obstet Gynecol 18: 371-375.
39. Todros T, Bontempo S, Piccoli E, et al. 2005. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 123: 162-166.
40. Traboulsi EI, Al-Khayer K, Matsumoto M, et al. 2002. Lymphedemadistichiasis syndrome and FOXC2 gene mutation. Am J Ophthalmol 134: 592-596.
41. Tranquilli AL, Bezzerccheri V, Giannubilo SR, Scaqnoli A, Mazzanti L, Garzetti GG. 2004a. Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol 113: 17-20.
42. Tranquilli AL, Giannubilo SR, Bezzerccheri V, Ciavattini A, Scaqnoli A, Mazzanti L. 2004b. Amniotic levels of nitric oxide and vascular endothelial growth factor in pregnancy with subsequent intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol 114: 162-165.
43. Tsukihara A, Tanemura M, Suzuki Y, Sato T, Tanaka T, Suzumori K. 2004. Reduction of pleural effusion by OK-432 in a fetus complicated with congenital hydrothorax. Fetal Diagn Ther 19: 327-331.
44. Uchiyama A, Morisaki T, Beppo K, et al. 1999. Hepatocyte growth factor and invasion-stimulatory activity are induced in pleural fluid by surgery in lung cancer patients. Br J Cancer 81: 721-726.
45. Weber AM, Philipson EH. 1992. Fetal pleural effusion: a review and meta-analysis for prognostic indicators. Obstet Gynecol 79: 281-286.
46. Yang KD, Stone RM, Lee CS, Chao TY, Cheng SN, Shaio MF. 1992. Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors. Cancer Immunol Immunother 35: 277-282.
47. Yoon BH, Jun JK, Romero R, et al. 1997. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal nbrain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 177: 19-26.
48. Zebrowski BK, Yano S, Liu W, et al. 1999. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 5: 3364-3368.
49. Zocchi L. 2002. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J 20: 1545-1558.